For example, analysis of RNA-sequencing (RNA-seq) data obtained from TCGA, which include 36 CCA tissues and 9 adjacent normal tissues, identified bloom syndrome helicase (BLM) as a potential CCA biomarker [65]. This evidence concerns the gene BLM and cholangiocarcinoma.